Antiproliferative effect of nonsteroidal antiinflammatory drugs against human colon cancer cells

Lee J. Hixson, David S Alberts, Mary Krutzsch, Janine Einsphar, Klaus Brendel, Paul H. Gross, Nancy Shipp Paranka, Monika Baier, Scott Emerson, Rifat Pamukcu, Randall W. Burt

Research output: Contribution to journalArticle

114 Citations (Scopus)

Abstract

Several lines of evidence suggest that nonsteroidal antiinflammatory drugs may be effective in preventing colorectal cancer. These include animal experiments, case-control studies, and clinical experience with sulindac in promoting the regression of adenomatous colon polyps in adenomatous polyposis coli. We determined the antiproliferative activity of various nonsteroidal antiinflammatory drugs, including two sulindac derivatives, against human colon cancer cells in vitro. Ht-29, SW480, and DLD-1 cells were continuously incubated with serial drug dilutions for 6 days prior to fixation. Cell number was determined using the sulforhodamine B assay, and drug concentrations which inhibited cell growth by 50% were estimated for each agent by interpolation. All drugs exhibited antiproliferative activity against Ht-29 and DLD-1 cells, and most inhibited SW480 cells. For Ht-29 cells, the 50% inhibitory concentration varied from 55 μM for diclofenac to 2100 μM for 5-aminosalicylic acid, with three drug groups of high, intermediate, and low potency evident. Inhibition of cell growth by sulindac sulfide was reversible following drug removal. Nonsteroidal antiinflammatory drugs exert an antiproliferative effect against human colon cancer cells with a wide range of potencies. A cytostatic response was demonstrated with sulindac sulfide. These data further support the potential role of these agents for chemoprevention of colorectal neoplasia.

Original languageEnglish (US)
Pages (from-to)433-438
Number of pages6
JournalCancer Epidemiology Biomarkers and Prevention
Volume3
Issue number5
StatePublished - 1994

Fingerprint

Colonic Neoplasms
Anti-Inflammatory Agents
Pharmaceutical Preparations
Sulindac
lissamine rhodamine B
Adenomatous Polyps
Mesalamine
Adenomatous Polyposis Coli
Diclofenac
Chemoprevention
Cytostatic Agents
Growth
Inhibitory Concentration 50
Case-Control Studies
Colorectal Neoplasms
Colon
Cell Count
Neoplasms

ASJC Scopus subject areas

  • Epidemiology
  • Oncology

Cite this

Hixson, L. J., Alberts, D. S., Krutzsch, M., Einsphar, J., Brendel, K., Gross, P. H., ... Burt, R. W. (1994). Antiproliferative effect of nonsteroidal antiinflammatory drugs against human colon cancer cells. Cancer Epidemiology Biomarkers and Prevention, 3(5), 433-438.

Antiproliferative effect of nonsteroidal antiinflammatory drugs against human colon cancer cells. / Hixson, Lee J.; Alberts, David S; Krutzsch, Mary; Einsphar, Janine; Brendel, Klaus; Gross, Paul H.; Paranka, Nancy Shipp; Baier, Monika; Emerson, Scott; Pamukcu, Rifat; Burt, Randall W.

In: Cancer Epidemiology Biomarkers and Prevention, Vol. 3, No. 5, 1994, p. 433-438.

Research output: Contribution to journalArticle

Hixson, LJ, Alberts, DS, Krutzsch, M, Einsphar, J, Brendel, K, Gross, PH, Paranka, NS, Baier, M, Emerson, S, Pamukcu, R & Burt, RW 1994, 'Antiproliferative effect of nonsteroidal antiinflammatory drugs against human colon cancer cells', Cancer Epidemiology Biomarkers and Prevention, vol. 3, no. 5, pp. 433-438.
Hixson, Lee J. ; Alberts, David S ; Krutzsch, Mary ; Einsphar, Janine ; Brendel, Klaus ; Gross, Paul H. ; Paranka, Nancy Shipp ; Baier, Monika ; Emerson, Scott ; Pamukcu, Rifat ; Burt, Randall W. / Antiproliferative effect of nonsteroidal antiinflammatory drugs against human colon cancer cells. In: Cancer Epidemiology Biomarkers and Prevention. 1994 ; Vol. 3, No. 5. pp. 433-438.
@article{5a5e338821884468b88bc5b561fe0681,
title = "Antiproliferative effect of nonsteroidal antiinflammatory drugs against human colon cancer cells",
abstract = "Several lines of evidence suggest that nonsteroidal antiinflammatory drugs may be effective in preventing colorectal cancer. These include animal experiments, case-control studies, and clinical experience with sulindac in promoting the regression of adenomatous colon polyps in adenomatous polyposis coli. We determined the antiproliferative activity of various nonsteroidal antiinflammatory drugs, including two sulindac derivatives, against human colon cancer cells in vitro. Ht-29, SW480, and DLD-1 cells were continuously incubated with serial drug dilutions for 6 days prior to fixation. Cell number was determined using the sulforhodamine B assay, and drug concentrations which inhibited cell growth by 50{\%} were estimated for each agent by interpolation. All drugs exhibited antiproliferative activity against Ht-29 and DLD-1 cells, and most inhibited SW480 cells. For Ht-29 cells, the 50{\%} inhibitory concentration varied from 55 μM for diclofenac to 2100 μM for 5-aminosalicylic acid, with three drug groups of high, intermediate, and low potency evident. Inhibition of cell growth by sulindac sulfide was reversible following drug removal. Nonsteroidal antiinflammatory drugs exert an antiproliferative effect against human colon cancer cells with a wide range of potencies. A cytostatic response was demonstrated with sulindac sulfide. These data further support the potential role of these agents for chemoprevention of colorectal neoplasia.",
author = "Hixson, {Lee J.} and Alberts, {David S} and Mary Krutzsch and Janine Einsphar and Klaus Brendel and Gross, {Paul H.} and Paranka, {Nancy Shipp} and Monika Baier and Scott Emerson and Rifat Pamukcu and Burt, {Randall W.}",
year = "1994",
language = "English (US)",
volume = "3",
pages = "433--438",
journal = "Cancer Epidemiology Biomarkers and Prevention",
issn = "1055-9965",
publisher = "American Association for Cancer Research Inc.",
number = "5",

}

TY - JOUR

T1 - Antiproliferative effect of nonsteroidal antiinflammatory drugs against human colon cancer cells

AU - Hixson, Lee J.

AU - Alberts, David S

AU - Krutzsch, Mary

AU - Einsphar, Janine

AU - Brendel, Klaus

AU - Gross, Paul H.

AU - Paranka, Nancy Shipp

AU - Baier, Monika

AU - Emerson, Scott

AU - Pamukcu, Rifat

AU - Burt, Randall W.

PY - 1994

Y1 - 1994

N2 - Several lines of evidence suggest that nonsteroidal antiinflammatory drugs may be effective in preventing colorectal cancer. These include animal experiments, case-control studies, and clinical experience with sulindac in promoting the regression of adenomatous colon polyps in adenomatous polyposis coli. We determined the antiproliferative activity of various nonsteroidal antiinflammatory drugs, including two sulindac derivatives, against human colon cancer cells in vitro. Ht-29, SW480, and DLD-1 cells were continuously incubated with serial drug dilutions for 6 days prior to fixation. Cell number was determined using the sulforhodamine B assay, and drug concentrations which inhibited cell growth by 50% were estimated for each agent by interpolation. All drugs exhibited antiproliferative activity against Ht-29 and DLD-1 cells, and most inhibited SW480 cells. For Ht-29 cells, the 50% inhibitory concentration varied from 55 μM for diclofenac to 2100 μM for 5-aminosalicylic acid, with three drug groups of high, intermediate, and low potency evident. Inhibition of cell growth by sulindac sulfide was reversible following drug removal. Nonsteroidal antiinflammatory drugs exert an antiproliferative effect against human colon cancer cells with a wide range of potencies. A cytostatic response was demonstrated with sulindac sulfide. These data further support the potential role of these agents for chemoprevention of colorectal neoplasia.

AB - Several lines of evidence suggest that nonsteroidal antiinflammatory drugs may be effective in preventing colorectal cancer. These include animal experiments, case-control studies, and clinical experience with sulindac in promoting the regression of adenomatous colon polyps in adenomatous polyposis coli. We determined the antiproliferative activity of various nonsteroidal antiinflammatory drugs, including two sulindac derivatives, against human colon cancer cells in vitro. Ht-29, SW480, and DLD-1 cells were continuously incubated with serial drug dilutions for 6 days prior to fixation. Cell number was determined using the sulforhodamine B assay, and drug concentrations which inhibited cell growth by 50% were estimated for each agent by interpolation. All drugs exhibited antiproliferative activity against Ht-29 and DLD-1 cells, and most inhibited SW480 cells. For Ht-29 cells, the 50% inhibitory concentration varied from 55 μM for diclofenac to 2100 μM for 5-aminosalicylic acid, with three drug groups of high, intermediate, and low potency evident. Inhibition of cell growth by sulindac sulfide was reversible following drug removal. Nonsteroidal antiinflammatory drugs exert an antiproliferative effect against human colon cancer cells with a wide range of potencies. A cytostatic response was demonstrated with sulindac sulfide. These data further support the potential role of these agents for chemoprevention of colorectal neoplasia.

UR - http://www.scopus.com/inward/record.url?scp=0028335192&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028335192&partnerID=8YFLogxK

M3 - Article

C2 - 7920212

AN - SCOPUS:0028335192

VL - 3

SP - 433

EP - 438

JO - Cancer Epidemiology Biomarkers and Prevention

JF - Cancer Epidemiology Biomarkers and Prevention

SN - 1055-9965

IS - 5

ER -